GT
Guided Therapeutics, Inc.
GTHP · OTC
$0.25 -0.80% (-$0.00)
1M +10.22%
Market Cap $23.9M
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 36.83x
P/E N/A
P/FFO N/A
Growth
100 /100
Growing Rev. growth 289.30%
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 64.00%
FCF margin 231.69%
Net margin 573.08%
Quality
10 /100
Poor ROIC 83.51%
Asset turnover 0.54x
ROA 311.72%
Debt
0 /100
High Current ratio 0.09x
Int. coverage -4.41x
Debt/Equity N/A
Stability
49 /100
Moderate Beta 0.69x
Profitable years 0
Rev. volatility 6,117.83%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GTHP
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Mark L. Faupel
Employees
3
Headquarters
Peachtree Corners